Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine versus pethidine for pain relief in femoral fracture
IRCT20231213060355N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in femoral fracture comparing Intravenous lidocaine with Intravenous pethidine (2 arms). Primary endpoints: Pain severity at 60 minutes and Incidence of adverse events. Started Jan 2024; status: completed.
02
Drugs
lidocainepethidine
03
Conditions
femoral fracture
Beyond the preview
Go deeper on IRCT20231213060355N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231213060355N1.